A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Objective: To determine the pharmacokinetic (PK) profile of a proprietary formulation of methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) in a phase 1 study. Methylphenidate extended-release orally disintegrating tablets (MPH XR-ODTs) combine two...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Child Adolesc Psychopharmacol
Main Authors: Childress, Ann, Newcorn, Jeffrey, Stark, Jeffrey G., McMahen, Russ, Tengler, Mark, Sikes, Carolyn
Formato: Artigo
Idioma:Inglês
Publicado: Mary Ann Liebert, Inc. 2016
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4991613/
https://ncbi.nlm.nih.gov/pubmed/27228207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2015.0261
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares